The Leuven-based start-up Antleron has set up a strategic partnership with the American 3D printing giant 3D Systems. Together they will play a pivotal role in advancing and accelerating breakthroughs in the biomedical industry.
Today, 3D Systems (NYSE:DDD) and Antleron are announcing a collaboration, intended to play a pivotal role in advancing and accelerating breakthroughs in the biomedical industry. Bringing together two industry pioneers – 3D Systems for 3D printing technologies and healthcare expertise, and Antleron for leadership and innovation in the development of regenerative products and personalized patient care - the companies will collaborate to support Antleron’s development of bioprinting solutions utilizing 3D Systems’ printing technologies.
“As we look to the future, bioprinting and regenerative medicine are large opportunities for 3D printing,” said Chuck Hull, co-founder and chief technology officer, 3D Systems. “The vision of Antleron is to sustainably bring living therapies into the clinic,” said Antleron CEO Jan Schrooten. “This entails personalized vaccines and cell-based therapies up to living tissues and organs, etc.”